Virax Biolabs Group Ltd. (VRAX) at a glance

Virax Biolabs Group Ltd. (VRAX) is a micro-cap Healthcare company. It trades at $2.82, with a 61.9% profit margin and revenue growth of 684.9%. It does not pay a dividend. Vestovix scores it 58/100 overall. Its strongest dimension is Growth (92/100) and its weakest is Momentum (13/100). It carries above-market volatility, so expect larger swings.

Price

$2.82

Market cap

$2.2M

P/E ratio

n/a

Dividend yield

None

Beta

1.34

52-week range

$2.50 to $21.75